GlaxoSmithKline Press Releases
Press Releases:
GlaxoSmithKline’s darapladib modifies coronary plaque composition and lowers Lp-PLA2 activity, a biomarker predictive of heart attack risk
- By GlaxoSmithKline
- Published 02-09-2008
- Technology
- Unrated
Results at ESC demonstrated that darapladib: − Prevented expansion of th...
GlaxoSmithKline and Valeant Pharmaceuticals announce worldwide collaboration agreement for retigabine
- By GlaxoSmithKline
- Published 28-08-2008
- Technology
- Unrated
Issued: Thursday 28 August 2008, London, UK, & Aliso Viejo, California ...
Significant reduction in rate of lung function decline achieved in COPD patients receiving Seretide/Advair
- By GlaxoSmithKline
- Published 15-08-2008
- Technology
- Unrated
- First study to show positive impact of treatment on important indicator of disease progression ...
GlaxoSmithKline and Genmab announce positive top-line results in ofatumumab chronic lymphocytic leukaemia pivotal study
- By GlaxoSmithKline
- Published 31-07-2008
- Technology
- Unrated
Phase III pivotal study of ofatumumab in refractory CLL meets primary endpoint ...
GlaxoSmithKline and the Harvard Stem Cell Institute announce a unique collaboration to enable the discovery of new medicines
- By GlaxoSmithKline
- Published 24-07-2008
- Technology
- Unrated
- Industry and academia link up in pioneering agreement ...
Results announcement for the second quarter 2008
- By GlaxoSmithKline
- Published 23-07-2008
- Technology
- Unrated
See the quarterly results page for more information. ...
GSK enters transformational agreement with Aspen to drive growth in emerging markets
- By GlaxoSmithKline
- Published 23-07-2008
- Technology
- Unrated
GlaxoSmithKline (GSK) today announced a transformational agreement to significantly extend its pharmaceutical p...
Dan Troy appointed as Senior Vice President and General Counsel for GlaxoSmithKline
- By GlaxoSmithKline
- Published 22-07-2008
- Technology
- Unrated
Issued – Tuesday 22nd July 2008 ...
GlaxoSmithKline teams up with academia to develop new medicines of value
- By GlaxoSmithKline
- Published 21-07-2008
- Technology
- Unrated
University of Cambridge to pioneer drug development by “academic incubators” ...
GlaxoSmithKline reaches settlement agreement with Biota
- By GlaxoSmithKline
- Published 21-07-2008
- Technology
- Unrated
Issued –Monday 21 July 2008, London, UK ...
GlaxoSmithKline and Actelion enter into exclusive collaboration to realise the full potential of almorexant in sleep disorders and beyond
- By GlaxoSmithKline
- Published 14-07-2008
- Technology
- Unrated
GlaxoSmithKline and Actelion to potentially co-develop and co-commercialise other orexin receptor antagonists ...
GSK receives BITC CommunityMark for global community programmes
- By GlaxoSmithKline
- Published 08-07-2008
- Technology
- Unrated
GlaxoSmithKline (GSK) today became one of the first companies to be awarded the new CommunityMark by the UK org...
GlaxoSmithKline to Appeal Judgment in Alabama Medicaid Pricing Suit
- By GlaxoSmithKline
- Published 02-07-2008
- Technology
- Unrated
PHILADELPHIA...
GSK and Aspen enter product divestment agreement
- By GlaxoSmithKline
- Published 01-07-2008
- Technology
- Unrated
Issued –Monday 30 June 2008, London, UK ...
GlaxoSmithKline responds to FDA on Cervarix and plans to submit final study data for approval
- By GlaxoSmithKline
- Published 30-06-2008
- Technology
- Unrated
Issued – Monday 30 June 2008, London, UK & Philadelphia, US ...
GSK update on FDA review of Promacta (eltrombopag)
- By GlaxoSmithKline
- Published 23-06-2008
- Technology
- Unrated
Issued – Friday 20 June 2008, London, UK & Philadelphia, PA ...
Cervarix™, GSK’s cervical cancer vaccine, wins tender for UK national immunisation programme
- By GlaxoSmithKline
- Published 18-06-2008
- Technology
- Unrated
Issued – Wednesday 18 June 2008, London, UK ...
GlaxoSmithKline responds to Government announcement on the PPRS
- By GlaxoSmithKline
- Published 18-06-2008
- Technology
- Unrated
Issued – Wednesday 18 June 2008, London, UK ...
GlaxoSmithKline and Mpex Pharmaceuticals form alliance to develop novel efflux pump inhibitors for use against serious gram-negative infections
- By GlaxoSmithKline
- Published 16-06-2008
- Technology
- Unrated
Potential to combine compounds with multiple new and existing antibiotics to create a broad offering of anti-infective medicines with activ...
Revolade (eltrombopag) data presented at EHA: updated data for EXTEND plus new data for REPEAT and DELPHI studies
- By GlaxoSmithKline
- Published 16-06-2008
- Technology
- Unrated
A further study reveals improved treatment tolerability as the most important unmet medical need in chronic ITP ...
U.S. FDA approves Requip XL™, the first and only oral once-daily non-ergot dopamine agonist for Parkinson’s disease
- By GlaxoSmithKline
- Published 14-06-2008
- Technology
- Unrated
Extended-Release Formulation Improved Symptoms in Patients Not Optimally Controlled with Levodopa and Reduced Patients’ “OffR...
GlaxoSmithKline receives marketing authorisation in the EU for Tyverb (lapatinib), the first oral targeted therapy for ErbB2-positive breast cancer
- By GlaxoSmithKline
- Published 12-06-2008
- Technology
- Unrated
Not for distribution to US Media ...
Phase III data show GSK paediatric candidate vaccine’s potential to provide improved protection against life-threatening pneumococcal diseases
- By GlaxoSmithKline
- Published 11-06-2008
- Technology
- Unrated
Based on pneumococcal serotype distribution in europe, candidate vaccine can be estimated to prevent over 80 % of invasive pneumoccocal dise...
Results from one year study suggest Seretide/Advair provides important benefits for African American patients with asthma
- By GlaxoSmithKline
- Published 10-06-2008
- Technology
- Unrated
Results suggested improvement in several endpoints for Seretide/Advair Diskus compared to ICS alone ...
GlaxoSmithKline acquires Sirtris Pharmaceuticals, Inc., a world leader in sirtuin research and development
- By GlaxoSmithKline
- Published 06-06-2008
- Technology
- Unrated
Issued – Friday 6 June 2008, London, UK, Ph...
GlaxoSmithKline and Boston’s Immune Disease Institute put scientists head-to-head in race for new discoveries
- By GlaxoSmithKline
- Published 03-06-2008
- Technology
- Unrated
Issued – Tuesday 3 June 2008, London,...
GlaxoSmithKline successfully completes tender offer for shares of Sirtris Pharmaceuticals
- By GlaxoSmithKline
- Published 03-06-2008
- Technology
- Unrated
Issued – Monday 2 June 2008, London, ...
